Nektar Therapeutics | NKTR - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Agios Pharmaceuticals USD 59.6M 264K 2026-06
ALKERMES USD 168.03M 489K 2026-09
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 541M 0 2026-09
Baxter International USD 517M 549K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Cara Therapeutics USD 9.38M 2.01K 2026-03
Cipla INR 807.87M 88K 2026-09
Dr.Reddys Laboratories INR 833.07M 382K 2026-09
Eisai JPY 282.46M 345K 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 244.68M 4.21M 2026-09
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 113.94M 106K 2026-09
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.65M 86K 2026-06
Merck USD 2.47B 1.05M 2026-06
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Neurocrine Biosciences USD 101.3M 750K 2026-09
Novartis USD 1.89B 12.09M 2026-09
Pfizer USD 5.7B 0 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Takeda JPY 1.58B 460K 2026-06
Teva Pharmaceutical Industries USD 1.17B 2M 2026-09
Xencor USD 74.33M 265K 2026-06